healthcare equipment near me scl healthcare
Early Diagnosis SCL domestic international healthcare
Disease prognosis services Asia prognosis vs diagnosis
south Korea Seoul prognosis hospital
On the 6th, Ahelz announced that they had conducted an investment agreement ceremony with Aiobio for the business of oral disease imaging diagnostic equipment.
Ahelz is a medical device and pharmaceutical distribution company within the SCL Healthcare Group. With this agreement, they plan to expand their business scope to include domestic and international sales of oral disease imaging diagnostic equipment.
Aiobio, on the other hand, plans to incorporate a specialized oral examination program into the 'Hanaro Medical Foundation.' Specifically, they will integrate oral chronic disease data into a Clinical Decision Support System (CDSS) using big data for disease prognosis services.
Both companies will initially focus on exploring the oral disease diagnostic testing market through Ahelz's comprehensive overseas sales network in Asia. In addition to securing potential customers among dental clinics in the area, they will also expand into public health projects.
Furthermore, there are plans to implement the 'Oral Examination and Education Services,' one of the fields of the 'Agricultural Happiness Bus' project executed by Aiobio in South Korea, tailored to each respective country. The 'Agricultural Happiness Bus,' jointly conducted by the Ministry of Agriculture, Food and Rural Affairs and the National Agricultural Cooperative Federation (Nonghyup), directly reaches rural areas and offers various services such as medical support, longevity photo shooting, inspections, and magnifier support free of charge.
Kim Jun-yeon, the CEO of Ahelz, emphasized, 'By incorporating oral disease diagnostic testing solutions into the overseas business sector of the SCL Healthcare Group, we will further expand our foothold in the diagnostic testing market.'
Yoon Hong-chul, the CEO of Aiobio, stated, 'Our company provides diagnostic equipment and software services that connect diseases, patients, hospitals, and individuals in the context of oral diseases.' He also expressed the significance of establishing a collaborative role structure in the long term, with Aiobio focusing on research and development, A&I handling manufacturing, and Ahelz responsible for sales.
